EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

HSV-1 as a Potential Driver of Alzheimer’s Disease

Dar-Yin Li iD, Eun Seok Choi iD, Xiaoyong Bao iD

Pathogens · 2025-10-08 · 14 (10) · 1022

DOI: 10.3390/pathogens14101022 ↗

At a glance

Übersichtsarbeit in Pathogens, published online on 2025-10-08. Written by Dar-Yin Li and 2 co-authors. Institution: John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX 77555, USA. Major MEDLINE topics: Alzheimer Disease, Herpesvirus 1, Human, Herpes Simplex. Cited 7 times so far (Crossref); 135 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIAID NIH HHS, NIH HHS, American Lung Association.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Herpes simplex virus type 1 (HSV-1) is a continuous health challenge, and current antiviral treatments cannot cure the virus. As life expectancy continues to increase worldwide, HSV-1 should remain a focus to minimize its associated health complications within the aging population. While often asymptomatic, HSV-1 causes oral and cutaneous lesions and establishes latency with periodic reactivation. Antivirals reduce symptoms but do not eradicate the virus. Emerging evidence links HSV-1 to Alzheimer’s disease (AD) via chronic neuroinflammation, amyloid-beta and tau accumulation, oxidative stress, and synaptic dysfunction, with viral proteins detected in AD-affected brain regions. This review assesses the current evidence for HSV-1 in dementia pathogenesis, examines antiviral strategies as potential neuroprotective interventions, and outlines the experimental models required to establish causality.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseHerpesvirus 1, HumanHerpes SimplexHumansAnimalsAntiviral AgentsAmyloid beta-Peptidestau Proteins

Author keywords

Alzheimer’s diseaseHSV-1HSV-1 experimental modelsdementia pathogenesis

Substances

Antiviral AgentsAmyloid beta-Peptidestau Proteins

Authors and institutions

  • John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Department of Pediatrics, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • The Institute of Translational Sciences, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • The Institute of Human Infections and Immunity, The University of Texas Medical Branch, Galveston, TX 77555, USA.

ORCID profiles: Dar-Yin Li, Eun Seok Choi, Xiaoyong Bao

Funding

  • NIAID NIH HHS
  • NIH HHS
  • American Lung Association
  • NIA NIH HHS
  • TARCC
  • US National Institutes of Health (NIH)
  • TARRC

Cite

APA

Li, D. Y., Choi, E. S., & Bao, X. (2025). HSV-1 as a Potential Driver of Alzheimer’s Disease. Pathogens, 14(10), 1022. https://doi.org/10.3390/pathogens14101022

Vancouver

Li DY, Choi ES, Bao X. HSV-1 as a Potential Driver of Alzheimer’s Disease. Pathogens. 2025;14(10):1022. doi:10.3390/pathogens14101022

BibTeX
@article{Li2025,
  author = {Li, Dar-Yin and Choi, Eun Seok and Bao, Xiaoyong},
  title = {HSV-1 as a Potential Driver of Alzheimer’s Disease},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {1022},
  doi = {10.3390/pathogens14101022}
}
Start for free →